Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEXAROTENE for Adult t-cell lymphoma/leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where BEXAROTENE was used for Adult t-cell lymphoma/leukaemia.

Most Reported Side Effects for BEXAROTENE

Side Effect Reports % Deaths Hosp.
Drug ineffective 67 8.8% 13 9
Hypothyroidism 65 8.6% 14 24
Death 53 7.0% 51 3
Hypertriglyceridaemia 44 5.8% 14 15
Off label use 32 4.2% 6 7
Disease progression 28 3.7% 14 13
Blood cholesterol increased 27 3.6% 0 6
Malignant neoplasm progression 26 3.4% 17 5
Pruritus 24 3.2% 0 2
Nausea 22 2.9% 1 1
Blood triglycerides increased 20 2.6% 0 2
Fatigue 20 2.6% 0 0
Dyslipidaemia 19 2.5% 3 6
Oedema peripheral 18 2.4% 0 13
Headache 17 2.2% 0 0

Other Indications for BEXAROTENE

Cutaneous t-cell lymphoma (266) Mycosis fungoides (125) Product used for unknown indication (90) T-cell lymphoma (24) Lymphoma (14) Cutaneous t-cell lymphoma stage iv (9) Neoplasm malignant (9) Peripheral t-cell lymphoma unspecified (8) Cutaneous lymphoma (7) Anaplastic large cell lymphoma t- and null-cell types (5)

Other Drugs Used for Adult t-cell lymphoma/leukaemia

LENALIDOMIDE (307) CYCLOPHOSPHAMIDE (281) DOXORUBICIN (281) VINCRISTINE (233) ETOPOSIDE (191) PREDNISOLONE (143) MOGAMULIZUMAB-KPKC (130) PREDNISONE (116) MOGAMULIZUMAB (115) CARBOPLATIN (101)

Related Pages

BEXAROTENE Full Profile All Adult t-cell lymphoma/leukaemia Drugs BEXAROTENE Demographics BEXAROTENE Timeline